RxDoctor Payments DataLook up a doctor →

Preeti Jhawar, DO

Gastroenterology · Westlake, OHNPI 1750572749

Payments from drug & device makers

$360,245in general payments, 2019–2025

Across 334 payments — averaging $1078.58 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Genentech, Inc.$318K
  • AbbVie$34K
  • Ironwood Pharmaceuticals, Inc$2K
  • Pfizer$595
  • Intercept Pharmaceuticals, Inc.$574
  • Janssen Scientific Affairs, LLC$473
  • plus $4K from 34 others

What the payments were for

  • Speaking & faculty fees$29,80071%
  • Travel & lodging$2,5766%
  • Food & beverage$9,75223%
  • Education$80%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$360,245 in reported general payments places this provider in the 90th percentile of 657 gastroenterology providers in Ohio.

See all gastroenterology providers in Ohio

Medicare billing

Part B allowed, 2024
$54,316
Medicare patients
152
Services billed
1,415

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
RinvoqUpadacitinib11$82,132
LinzessLinaclotide82$45,030
Lubiprostone53$4,603
Omeprazole271$2,642
Budesonide DrBudesonide14$2,592
Gavilyte-GPeg3350/Sod Sulf,bicarb,cl/Kcl143$1,945
Pantoprazole Sodium74$1,501
Budesonide EcBudesonide11$1,348
Peg-3350 And ElectrolytesPeg3350/Sod Sulf,bicarb,cl/Kcl35$547
Dicyclomine Hcl19$240
Famotidine27$142

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieRinvoq, Linzess$33,925$127,16293 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 657 gastroenterology providers in Ohio.

Other gastroenterology in Westlake

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →